Biotech Focuses on Gene Therapy for Huntington’s, Heart Disease, Hemophilia B
News
Gene therapy biotech uniQure is prioritizing its drug pipeline to develop treatments for Huntington’s disease, hemophilia B, and its partnered gene therapy programs associated with uniQure’s collaboration with Bristol-Myers Squibb (BMS) in ... Read more